Program
PA5108
A development code. Also written as “PA5108 Ocular Implant low dose”, “PA5108 Ocular Implant, high dose” and “PA5108 Latanoprost FA SR Ocular Implant”.
Its studies are mostly in Glaucoma, Open-Angle, led by PolyActiva Pty.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| PolyActiva Pty | 31 open or running | phase 2since Mar 25, 2025 | Jul 10, 2018 | none ahead |
Also a collaborator on its studies: iuvo-s-r-l.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jul 10, 2018First study: phase 1 study in Glaucoma, Open-AngleFirst studyNCT03604328 · 8 enrolled · Australia
- Aug 5, 2019Phase 1 study in Glaucoma, Open-AngleNCT04060758 · 37 enrolled · Australia, New Zealand
- Mar 25, 2025Phase 2 study in Glaucoma, Open-AngleNCT06964191 · 75 enrolled · United States
Ahead
- Nov 15, 2026Primary completion: phase 2 study in Glaucoma, Open-AngleNCT06964191
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 3 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT06964191Glaucoma, Open-Angle · United States | 2 | Active, not recruiting | Nov 15, 2026 | 75 |
| NCT04060758Glaucoma, Open-Angle · Australia, New Zealand | 1 | Completed | May 13, 2025 | 37 |
| NCT03604328Glaucoma, Open-Angle · Australia | 1 | Completed | Jun 15, 2020 | 8 |
How it is read
Names in the registry
- “PA5108 Ocular Implant low dose”, 1 entry
- “PA5108 Ocular Implant, high dose”, 1 entry
- “PA5108 Latanoprost FA SR Ocular Implant”, 1 entry
- “PA5108”, 1 entry
Codes read as this program: PA5108.
Conditions, from the studies’ own filings
- Glaucoma, Open-Angle, 3 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.